Monday, March 12, 2018 10:45:10 AM
$ETBI: NEXT BIG OTC BIOTECH RUNNER
52 WEEK HIGH=.045, CURRENTLY ONLY .0054 HUGE UPSIDE!
NON-DILUTIVE FINANCING, CLEAN LEVEL II
$ETBI IS LOOKING LIKE A GREAT TURNAROUND STORY DEVELOPING.
RECENT NEWS
EastGate Biotech Announces Licensing/Distribution MOU With BuPharco for the Insulin Mouth Rinse in the Philippines for Type 2 Diabetes Patients
ACCESSWIRE | 03/05/2018
Eastgate Biotech Provides Corporate Update
ACCESSWIRE | 03/01/2018
GOOD READS:
Eastgate Biotech Corp. (OTC: ETBI) on the Diabetic Road to Recovery
FUD on Eastgate Biotech Could be Last Stand for Naked Short Position
EastGate Biotech (OTC Pink: ETBI) Finds Non-Dilutive Sweet Spot in Philippines
Eastgate Biotech Corp Website
52 WEEK HIGH=.045, CURRENTLY ONLY .0054 HUGE UPSIDE!
NON-DILUTIVE FINANCING, CLEAN LEVEL II
$ETBI IS LOOKING LIKE A GREAT TURNAROUND STORY DEVELOPING.
RECENT NEWS
EastGate Biotech Announces Licensing/Distribution MOU With BuPharco for the Insulin Mouth Rinse in the Philippines for Type 2 Diabetes Patients
ACCESSWIRE | 03/05/2018
Eastgate Biotech Provides Corporate Update
ACCESSWIRE | 03/01/2018
GOOD READS:
Eastgate Biotech Corp. (OTC: ETBI) on the Diabetic Road to Recovery
FUD on Eastgate Biotech Could be Last Stand for Naked Short Position
EastGate Biotech (OTC Pink: ETBI) Finds Non-Dilutive Sweet Spot in Philippines
Eastgate Biotech Corp Website
"Well, life all comes down to a few moments, this is one of them."
Disclaimer: Anything I write here is Just My Opinion
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
